- Home
- CHCI vs DERM Comparison
CHCI vs DERM Comparison
Compare CHCI & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHCI
- DERM
- Stock Information
- Founded
- CHCI 1985
- DERM 2014
- Country
- CHCI United States
- DERM United States
- Employees
- CHCI N/A
- DERM N/A
- Industry
- CHCI Building operators
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- CHCI Real Estate
- DERM Health Care
- Exchange
- CHCI Nasdaq
- DERM Nasdaq
- Market Cap
- CHCI 68.9M
- DERM 107.4M
- IPO Year
- CHCI 2004
- DERM 2021
- Fundamental
- Price
- CHCI $6.56
- DERM $5.34
- Analyst Decision
- CHCI
- DERM Strong Buy
- Analyst Count
- CHCI 0
- DERM 2
- Target Price
- CHCI N/A
- DERM $10.00
- AVG Volume (30 Days)
- CHCI 10.1K
- DERM 51.2K
- Earning Date
- CHCI 03-24-2025
- DERM 05-12-2025
- Dividend Yield
- CHCI N/A
- DERM N/A
- EPS Growth
- CHCI N/A
- DERM N/A
- EPS
- CHCI 0.59
- DERM N/A
- Revenue
- CHCI $45,402,000.00
- DERM $57,771,000.00
- Revenue This Year
- CHCI N/A
- DERM N/A
- Revenue Next Year
- CHCI N/A
- DERM $36.49
- P/E Ratio
- CHCI $11.82
- DERM N/A
- Revenue Growth
- CHCI 5.57
- DERM N/A
- 52 Week Low
- CHCI $4.60
- DERM $2.85
- 52 Week High
- CHCI $14.48
- DERM $6.89
- Technical
- Relative Strength Index (RSI)
- CHCI 33.67
- DERM 56.65
- Support Level
- CHCI $6.31
- DERM $4.85
- Resistance Level
- CHCI $7.27
- DERM $5.33
- Average True Range (ATR)
- CHCI 0.37
- DERM 0.32
- MACD
- CHCI -0.03
- DERM -0.03
- Stochastic Oscillator
- CHCI 16.45
- DERM 41.48
About CHCI Comstock Holding Companies Inc.
Comstock Holding Co Inc is a developer and manager of mixed-use and transit-oriented properties with operations that are majorly focused on the Washington, D.C. metropolitan area. It provides a range of services such as asset management, property management, development and construction management, and other real estate-related services to its asset-owning clients, composed predominantly of institutional real estate investors, high net worth family offices, financial institutions, and governmental bodies seeking to enhance their surrounding communities by developing real estate through public-private partnerships.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.